Abstract
AbstractThe (l‐hydroxy‐4‐amino‐butylidene‐l,l‐bisphosphate) (ABP) is a compound that inhibits bone resorption, and a highly effective drug in the treatment of metastatic bone disease. The fac‐[99mTc(CO)3(H2O)3]+ precursor was reacted with ABP in saline (pH=3–4) at 45°C for 15 min to produce the 99mTc(CO)3–ABP complex. The radiochemical purity (RCP) of the product was over 90% as measured by thin layer chromatography and high‐performance liquid chromatography. No decomposition of the complex at room temperature (25°C) was observed over a period of 6 h. Its partition coefficient indicated that it was a weak hydrophilic complex. The biodistribution in normal mice of 99mTc(CO)3–ABP complex differed greatly from that of 99mTc–ABP, and the former had a lower bone uptake as compared with that of the latter. The experiment results showed that the incorporation of the [99mTc(CO)3]+ core into the ABP ligand may drastically change the characterization and biological features as compared with 99mTc–ABP. Copyright © 2007 John Wiley & Sons, Ltd.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Labelled Compounds and Radiopharmaceuticals
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
